TY - JOUR T1 - One-year outcomes of the multi-center study to transplant hepatitis C-infected kidneys (MYTHIC) Trial JF - Kidney Int Rep Y1 - 2021 A1 - Sise, ME A1 - Goldberg, DS A1 - Schaubel, DE A1 - et, al KW - cytomegalovirus infection KW - Direct-acting antivirals KW - Glecaprevir/pibrentasvir KW - hepatitis C virus KW - Kidney Transplantation KW - organ allocation VL - 7 SP - 241-250 UR - https://doi.org/10.1016/j.ekir.2021.11.022 IS - 2 ER -